Jeewon Chon MA , Ashley Treanor BS , Andrew C. Pickles BS , William Y. Shin BA , Ronak H. Jani MD , John T. Tsiang MD , Amy Wozniak MS , Anthony W. Kam MD, PhD , David P. Pasquale MD , Joseph C. Serrone MD , Brandon J. Bond MD
{"title":"Improved outcome prediction in large vessel occlusion stroke: A comparison of Tmax-based hypoperfusion ratios HIR10/4 and HIR10/6","authors":"Jeewon Chon MA , Ashley Treanor BS , Andrew C. Pickles BS , William Y. Shin BA , Ronak H. Jani MD , John T. Tsiang MD , Amy Wozniak MS , Anthony W. Kam MD, PhD , David P. Pasquale MD , Joseph C. Serrone MD , Brandon J. Bond MD","doi":"10.1016/j.jstrokecerebrovasdis.2025.108504","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The hypoperfusion intensity ratio (HIR), derived from CT perfusion (CTP), reflects collateral flow quality, but its optimal formulation remains unsettled.</div></div><div><h3>Objective</h3><div>To compare the prognostic utility of conventional HIR<sub>10/6</sub> (time-to-maximum [T<sub>max</sub>] >10s / >6 s) with an alternative HIR<sub>10/4</sub> (T<sub>max</sub> >10s / >4 s) in patients undergoing endovascular thrombectomy (EVT).</div></div><div><h3>Methods</h3><div>We retrospectively analyzed consecutive large-vessel occlusion (LVO) strokes treated with EVT at our quaternary academic medical center (2015–2024). CTP was processed using RAPID software. Primary outcomes were modified Rankin Scale (mRS) at discharge and at 90 days. Secondary outcomes included National Institutes of Health Stroke Scale (NIHSS) at discharge and hemorrhagic transformation on follow-up imaging. Ordinal and linear regression models were adjusted for age, sex, vascular risk factors, intravenous thrombolysis, presentation window, and transfer status. Receiver operating characteristic (ROC) curves assessed discriminative performance.</div></div><div><h3>Results</h3><div>Among 280 patients (mean age 70 ±15 years; 49 % male), mean HIR<sub>10/6</sub> was 0.418 and HIR<sub>10/4</sub> was 0.241. Each 0.1-unit increase in HIR<sub>10/4</sub> translated to 31 % higher odds of worse mRS at discharge (adjusted odds ratio [aOR] 1.31, 95 % CI 1.12–1.54; <em>p</em>=0.001), 24 % higher odds of worse mRS at 90 days (aOR 1.24, 95 % CI 1.04–1.48; <em>p</em>=0.016), and higher discharge NIHSS (β=0.88, 95 % CI 0.05–1.71; <em>p</em>=0.039). HIR<sub>10/6</sub> showed weaker associations and was not significant for discharge NIHSS. Neither HIR metric demonstrated meaningful discrimination for hemorrhagic transformation or dichotomized outcomes (area under the curve [AUC] 0.50–0.52).</div></div><div><h3>Conclusions</h3><div>Incorporating mildly delayed tissue (T<sub>max</sub> >4 s) may enhance the physiologic sensitivity of HIR. HIR<sub>10/4</sub> may be a potential prognostic biomarker; however, prospective validation is needed, and its standalone ability to discriminate binary outcomes remains limited.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 12","pages":"Article 108504"},"PeriodicalIF":2.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305725002812","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The hypoperfusion intensity ratio (HIR), derived from CT perfusion (CTP), reflects collateral flow quality, but its optimal formulation remains unsettled.
Objective
To compare the prognostic utility of conventional HIR10/6 (time-to-maximum [Tmax] >10s / >6 s) with an alternative HIR10/4 (Tmax >10s / >4 s) in patients undergoing endovascular thrombectomy (EVT).
Methods
We retrospectively analyzed consecutive large-vessel occlusion (LVO) strokes treated with EVT at our quaternary academic medical center (2015–2024). CTP was processed using RAPID software. Primary outcomes were modified Rankin Scale (mRS) at discharge and at 90 days. Secondary outcomes included National Institutes of Health Stroke Scale (NIHSS) at discharge and hemorrhagic transformation on follow-up imaging. Ordinal and linear regression models were adjusted for age, sex, vascular risk factors, intravenous thrombolysis, presentation window, and transfer status. Receiver operating characteristic (ROC) curves assessed discriminative performance.
Results
Among 280 patients (mean age 70 ±15 years; 49 % male), mean HIR10/6 was 0.418 and HIR10/4 was 0.241. Each 0.1-unit increase in HIR10/4 translated to 31 % higher odds of worse mRS at discharge (adjusted odds ratio [aOR] 1.31, 95 % CI 1.12–1.54; p=0.001), 24 % higher odds of worse mRS at 90 days (aOR 1.24, 95 % CI 1.04–1.48; p=0.016), and higher discharge NIHSS (β=0.88, 95 % CI 0.05–1.71; p=0.039). HIR10/6 showed weaker associations and was not significant for discharge NIHSS. Neither HIR metric demonstrated meaningful discrimination for hemorrhagic transformation or dichotomized outcomes (area under the curve [AUC] 0.50–0.52).
Conclusions
Incorporating mildly delayed tissue (Tmax >4 s) may enhance the physiologic sensitivity of HIR. HIR10/4 may be a potential prognostic biomarker; however, prospective validation is needed, and its standalone ability to discriminate binary outcomes remains limited.
期刊介绍:
The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.